- Home
- MREO vs RDVT Comparison
MREO vs RDVT Comparison
Compare MREO & RDVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- RDVT
- Stock Information
- Founded
- MREO 2015
- RDVT 2017
- Country
- MREO United Kingdom
- RDVT United States
- Employees
- MREO N/A
- RDVT N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- RDVT Computer Software: Prepackaged Software
- Sector
- MREO Health Care
- RDVT Technology
- Exchange
- MREO Nasdaq
- RDVT Nasdaq
- Market Cap
- MREO 369.2M
- RDVT 538.6M
- IPO Year
- MREO N/A
- RDVT N/A
- Fundamental
- Price
- MREO $2.49
- RDVT $39.33
- Analyst Decision
- MREO Strong Buy
- RDVT Strong Buy
- Analyst Count
- MREO 6
- RDVT 1
- Target Price
- MREO $7.83
- RDVT $25.00
- AVG Volume (30 Days)
- MREO 1.4M
- RDVT 94.3K
- Earning Date
- MREO 05-14-2025
- RDVT 05-07-2025
- Dividend Yield
- MREO N/A
- RDVT 0.76%
- EPS Growth
- MREO N/A
- RDVT N/A
- EPS
- MREO N/A
- RDVT 0.50
- Revenue
- MREO $1,000,000.00
- RDVT $75,189,000.00
- Revenue This Year
- MREO N/A
- RDVT $15.93
- Revenue Next Year
- MREO N/A
- RDVT $13.85
- P/E Ratio
- MREO N/A
- RDVT $78.38
- Revenue Growth
- MREO N/A
- RDVT 24.89
- 52 Week Low
- MREO $2.25
- RDVT $16.56
- 52 Week High
- MREO $5.02
- RDVT $43.44
- Technical
- Relative Strength Index (RSI)
- MREO 42.82
- RDVT 55.42
- Support Level
- MREO $2.49
- RDVT $37.89
- Resistance Level
- MREO $2.63
- RDVT $39.43
- Average True Range (ATR)
- MREO 0.14
- RDVT 1.59
- MACD
- MREO 0.02
- RDVT 0.19
- Stochastic Oscillator
- MREO 41.38
- RDVT 93.81
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About RDVT Red Violet Inc.
Red Violet Inc is a software and services company. It specializes in big data analysis, providing cloud-based, mission-critical information solutions to enterprises in a variety of industries. Through its CORE data fusion platform, it provides mission-critical information about individuals, businesses and assets.